INmune Bio GAAP EPS of -$1.67 misses by $0.02, revenue of $0.15M beats by $0.01M

seekingalpha03-29

INmune Bio press release (NASDAQ:INMB): FY GAAP EPS of -$1.67 misses by $0.02. Revenue of $0.15M (-59.5% Y/Y) beats by $0.01M. More on INmune Bio INmune Bio: Caution Still Warranted But ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2423123708?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-29 04:06","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2423123708","market":"us","top_or_hot":-1,"title":"INmune Bio GAAP EPS of -$1.67 misses by $0.02, revenue of $0.15M beats by $0.01M","media":"seekingalpha","content":"<div>\n<p>INmune Bio press release  (NASDAQ:INMB): FY  GAAP EPS of -$1.67  misses by $0.02.\nRevenue of $0.15M (-59.5% Y/Y)  beats by $0.01M.\n\n\nMore on INmune Bio  INmune Bio: Caution Still Warranted But ...</p>\n\n<a href=\"https://seekingalpha.com/news/4085143-inmune-bio-gaap-eps-of-1_67-misses-0_02-revenue-of-0_15m-beats-0_01m\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INmune Bio GAAP EPS of -$1.67 misses by $0.02, revenue of $0.15M beats by $0.01M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINmune Bio GAAP EPS of -$1.67 misses by $0.02, revenue of $0.15M beats by $0.01M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-29 04:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4085143-inmune-bio-gaap-eps-of-1_67-misses-0_02-revenue-of-0_15m-beats-0_01m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>INmune Bio press release  (NASDAQ:INMB): FY  GAAP EPS of -$1.67  misses by $0.02.\nRevenue of $0.15M (-59.5% Y/Y)  beats by $0.01M.\n\n\nMore on INmune Bio  INmune Bio: Caution Still Warranted But ...</p>\n\n<a href=\"https://seekingalpha.com/news/4085143-inmune-bio-gaap-eps-of-1_67-misses-0_02-revenue-of-0_15m-beats-0_01m\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QQQ","symbol_name":"纳指100ETF","start_time":0,"source_url":"https://seekingalpha.com/news/4085143-inmune-bio-gaap-eps-of-1_67-misses-0_02-revenue-of-0_15m-beats-0_01m","article_id":"2423123708","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2423123708","pubTimestamp":1711656383,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"INmune Bio press release  : FY  GAAP EPS of -$1.67  misses by $0.02.More on INmune Bio  INmune Bio: Caution Still Warranted But Upgrading To Hold Seeking Alpha’s Quant Rating on INmune Bio Historical earnings data for INmune Bio Financial information for INmune Bio","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","INMB":"INmune Bio Inc","BK4139":"生物科技","SQQQ":"纳指三倍做空ETF",".IXIC":"NASDAQ Composite","PSQ":"纳指反向ETF","TQQQ":"纳指三倍做多ETF","QID":"纳指两倍做空ETF"},"translate_title":"INmune Bio GAAP每股收益-1.67美元低于预期0.02美元收入15万美元超过预期10万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INMB":1,".IXIC":0.63,"MNQmain":0.6,"NQmain":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"SQQQ":0.6,"TQQQ":0.6},"content_text":"INmune Bio press release  (NASDAQ:INMB): FY  GAAP EPS of -$1.67  misses by $0.02.\nRevenue of $0.15M (-59.5% Y/Y)  beats by $0.01M.\n\n\nMore on INmune Bio  INmune Bio: Caution Still Warranted But Upgrading To Hold Seeking Alpha’s Quant Rating on INmune Bio Historical earnings data for INmune Bio Financial information for INmune Bio","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2423123708"}